Shana E McCormack,David R Weber,David R Lynch
Shana E McCormack
Daniel Ciampi de Andrade,Veit Mylius,Santiago Perez Lloret
Daniel Ciampi de Andrade
Impaired Gait, Postural Instability, and Rigidity in Relation to CB1 Receptor Availability in Parkinson's Disease [0.03%]
帕金森病患者步态异常、姿势不稳定和肌张力亢进与CB1受体占有率之间的关系
Riikka Ajalin,Haidar Al-Abdulrasul,Jouni M Tuisku et al.
Riikka Ajalin et al.
Background: In Parkinson's disease (PD), postural instability and gait disorder (PIGD) symptoms are associated with a worse prognosis for an unknown reason. ...
Prospective Connectomic-Based Deep Brain Stimulation Programming for Parkinson's Disease [0.03%]
基于预测连接组学的帕金森病深部脑刺激编程方法研究
Kevin Hines,Angela M Noecker,Anneke M Frankemolle-Gilbert et al.
Kevin Hines et al.
Background: Efficacy of deep brain stimulation (DBS) relies on accurate lead placement as well as optimization of the stimulation parameters. Although clinical software tools are now available, programming still largely r...
First Evidence for Disease-Modifying Treatment of SLC20A2-Related Primary Familial Brain Calcification [0.03%]
SLC20A2相关原发性家族性脑钙化的首项疾病修正治疗证据
Alexander Balck,Christine Klein
Alexander Balck
Reply to: Comment on De Giorgis et al. "Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome-Associated Paroxysmal Movement Disorders" [0.03%]
对De Giorgis等关于“Triheptanoin治疗Glut1缺乏症相关阵发性运动障碍随机三期临床研究”的评论的回复
Valentina De Giorgis,Darryl C De Vivo
Valentina De Giorgis
Dusan Hirjak,Andreas Meyer-Lindenberg,Georg Northoff
Dusan Hirjak
Kevin J Black,Sarah C Grossen,Amanda L Arbuckle et al.
Kevin J Black et al.
Comment to: "Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome-Associated Paroxysmal Movement Disorders" [0.03%]
对“关于Glut1缺乏综合征相关阵发性运动障碍的Triheptanoin III期随机研究”的评述
Emmanuel Roze,Aurélie Méneret,Elodie Hainque et al.
Emmanuel Roze et al.